Hussain, Md. Sarfaraj and Azam, Faizul and Ahamed, K. F. H. Nazeer and Ravichandiran, V. and Alkskas, Ismail (2016) Anti-endotoxin effects of terpenoids fraction from Hygrophila auriculata in lipopolysaccharide-induced septic shock in rats. Pharmaceutical Biology, 54 (4). pp. 628-636. ISSN 1388-0209
![[thumbnail of PB-2015.pdf]](https://ir.vistas.ac.in/style/images/fileicons/archive.png)
PB-2015.pdf
Download (428kB)
Abstract
Context: Hygrophila auriculata (K. Schum) Heine (Acanthaceae) has been traditionally used for
the treatment of various ailments such as inflammation, rheumatism, jaundice and malaria.Objective: The present study aims to separate terpenoid fraction (TF) from alcohol (70%) extract of the whole plant of Hygrophila auriculata and assess its anti-inflammatory activity.
Materials and methods: HPTLC analysis of TF was performed for the estimation of lupeol. Edema was induced in Wistar albino rats by subplanter injection of 0.1 ml of 1% (w/v) carrageenan into
the right hind paw after 1 h of TF administration (100 and 200 mg/kg oral). Septic shock was
induced by intraperitoneal administration of LPS (100 mg/kg) in rats and interleukins (IL-1b and
IL-6), tumor necrosis factor (TNF-a), superoxide dismutase (SOD), lipid peroxidation (LPO), and
nitric oxide (NO) were measured in serum. AutoDock 4.2 was used for molecular docking.
Results: Administration of TF significantly (p50.005) restored the serum levels of cytokines, LPO
(7.77 ± 0.034 versus 4.59 ± 0.059 nmole of TBARS), NO (9.72 ± 0.18 versus 4.15 ± 0.23 mmol nitrite/
mg of wet tissue), and SOD (4.89 ± 0.036 versus 7.83 ± 0.033 Unit/mg protein) compared with the LPS-challenged rats. Analysis of in silico results revealed that TNF-a is the most appropriate target in eliciting anti-inflammatory activity.Conclusion: The present findings suggest that TF of Hygrophila auriculata possesses great promise as an anti-inflammatory agent which may be due to its antioxidant effect. Molecular docking results could be exploited for lead optimization and development of suitable
treatment of inflammatory disorders.
Item Type: | Article |
---|---|
Subjects: | Pharmaceutics > Cardiovascular System |
Divisions: | Pharmaceutics |
Depositing User: | Mr IR Admin |
Date Deposited: | 02 Oct 2024 09:43 |
Last Modified: | 02 Oct 2024 09:43 |
URI: | https://ir.vistas.ac.in/id/eprint/8100 |